BIOSIMILAR PROTEIN IMMUNOTHERAPY - Trademark Details
Status: 630 - New Application - Record Initialized Not Assigned To Examiner
Image for trademark with serial number 98171713
Serial Number
98171713
Word Mark
BIOSIMILAR PROTEIN IMMUNOTHERAPY
Status
630 - New Application - Record Initialized Not Assigned To Examiner
Status Date
2023-09-12
Filing Date
2023-09-08
Statements
Indication of Colors claimed
The color(s) orange, yellow, dark blue, light blue, dark green, light green, purple, and pink is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a cross shape with the outer corners outlined in orange, yellow, dark blue, light blue, dark green, light green, purple, and pink. To the right is the stylized wording BIOSIMILAR PROTEIN IMMUNOTHERAPY.
Goods and Services
Medical services; Health care services, namely, natural allergy desensitization using exposure immunotherapy; Advice relating to allergies; Medical services, namely, the treatment of food allergies
Classification Information
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2023-09-12
Primary Code
044
First Use Anywhere Date
2023-08-15
First Use In Commerce Date
2023-08-15
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Joshua M. Gerben, Esq.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2023-09-12NEW APPLICATION ENTERED
2023-09-12TEAS CHANGE OF OWNER ADDRESS RECEIVED
2023-09-12APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2023-09-12TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2023-09-12ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2023-09-12TEAS CHANGE OF CORRESPONDENCE RECEIVED